Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Angioleiomyomas of the Extremities and Trunk: An Observational Study.

Academic radiology·2024
Same author

Baseline immune state and T-cell clonal kinetics are associated with durable response to CAR-T therapy in large B-cell lymphoma.

Blood·2024
Same author

Asymmetric uptake on molecular breast imaging: A manifestation of unilateral breastfeeding.

Radiology case reports·2024
Same author

Development of a deep learning model for the automated detection of green pixels indicative of gout on dual energy CT scan.

Research in diagnostic and interventional imaging·2024
Same author

Deep-learning for automated detection of MSU deposits on DECT: evaluating impact on efficiency and reader confidence.

Frontiers in radiology·2024

Related Experiment Video

Updated: Jul 8, 2026

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
07:05

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

Angiosarcoma of the breast.

Katrina N Glazebrook1, Maureen J Magut, Carol Reynolds

  • 1Department of Radiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.

AJR. American Journal of Roentgenology
|January 24, 2008
PubMed
Summary
This summary is machine-generated.

Rare breast angiosarcomas, both primary and secondary, can mimic bruises, delaying diagnosis. Imaging is nonspecific, but MRI can help assess high-grade tumor extent.

More Related Videos

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Related Experiment Videos

Last Updated: Jul 8, 2026

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
07:05

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Angiosarcomas are rare breast tumors.
  • Post-irradiation angiosarcomas are increasing with breast conservation therapy.
  • Clinical presentation can be nonspecific, mimicking bruising.

Purpose of the Study:

  • To describe imaging findings of primary and secondary breast angiosarcomas.
  • To correlate imaging with pathologic findings.
  • To outline the clinical presentation of these rare tumors.

Main Methods:

  • Review of imaging findings (mammography, ultrasound, MRI).
  • Pathologic correlation of imaging features.
  • Clinical presentation analysis.

Main Results:

  • Imaging findings are often nonspecific.
  • Bruiselike skin discoloration is a common presentation, potentially delaying diagnosis.
  • MRI may reveal rapid enhancement and washout in high-grade tumors, aiding in extent determination.

Conclusions:

  • Increasing incidence of post-irradiation angiosarcoma necessitates awareness.
  • Early recognition of nonspecific signs like bruising is crucial.
  • MRI can be valuable for assessing tumor extent in high-grade angiosarcomas.